Patent · US Active

High level expression of recombinant toxin proteins

US8906636B2 · kind B2 · utility

0Cited by
41References
18Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 26, 2013
Grant dateDec 9, 2014
Priority date
Expiry dateJul 26, 2033

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Y304/24068
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

The present invention relates to the field of recombinant toxin protein production in bacterial hosts. In particular, the present invention relates to production processes for obtaining high levels of a recombinant CRM197, Diphtheria Toxin, Pertussis Toxin, Tetanus Toxoid Fragment C, Cholera Toxin B, Cholera holotoxin, and Pseudomonas Exotoxin A, from a bacterial host.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.